Chronic kidney disease (CKD) affects 10% of the global population, among which renal fibrosis is a progressive process that can lead to end-stage renal failure. Early diagnosis and active monitoring ...

A new guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) group provides updated recommendations on the management of anemia in chronic kidney disease (CKD), reflecting substantial ...

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) and published online Dec. 30 in the Annals of Internal Medicine, ...

Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment. SGLT2i are recommended for CKD patients, regardless of diabetes status, for kidney and cardiovascular ...

With over 12 million Filipinos affected and billions lost to treatment costs, CKD remains one of the country’s most underdiagnosed and costly health threats—demanding urgent, collective action.

The full guideline included 28 recommendations for which there is the greatest evidence and 141 practice points, which reflect the expert opinion of the group. HealthDay News — In a 2024 clinical ...

An arsenal of highly effective medications now represent pillars in the prevention of chronic kidney disease (CKD) progression, yet with the drugs under-utilized among patients who need them the most, ...

Each month, Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Each year there are 3.9 ...

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Chronic kidney disease (CKD) is a public health challenge that affects more than 800 million people worldwide. 1 CKD can be caused by a variety of disease processes. Many causes are difficult to ...